Jiangsu Shenhua Pharmaceutical Co., Ltd

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Jiangsu Shenhua Pharmaceutical Co., Ltd

Is Jiangsu Shenhua Pharmaceutical Co., Ltd on an FDA import alert?

Yes. As of October 27, 2026, Jiangsu Shenhua Pharmaceutical Co., Ltd is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for cordyceps extract powder; FDA published the listing on September 22, 2023.

Has FDA refused shipments from Jiangsu Shenhua Pharmaceutical Co., Ltd?

Yes. FDA refused 1 shipment line from Jiangsu Shenhua Pharmaceutical Co., Ltd on August 14, 2026. The most recent, on August 14, 2026, was herbals & botanicals (not teas), n.e.c., charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Jiangsu Shenhua Pharmaceutical Co., Ltd's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

What is Jiangsu Shenhua Pharmaceutical Co., Ltd's FEI number?

Jiangsu Shenhua Pharmaceutical Co., Ltd's FDA Establishment Identifier (FEI) is 3012130479.

Can shipments from Jiangsu Shenhua Pharmaceutical Co., Ltd still enter the U.S.?

Shipments of cordyceps extract powder from Jiangsu Shenhua Pharmaceutical Co., Ltd can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).